CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pfizer Inc v. Teva Pharmaceuticals USA Inc.

1:08-cv-00237

Overview

Case Number 1:08-cv-00237
Filing Date 2008-04-25
Status Terminated
Termination Date 2009-08-17
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Warner-Lambert Company NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Rudolf E. Hutz

Reed Smith LLP

Tel: +1 (302) 778-7571
Fax: +1 (302) 658-5614

1201 Market Street, Suite 1500

Pfizer Inc Operating Company

Represented By

1 Attorneys Listed

Rudolf E. Hutz

Reed Smith LLP

Tel: +1 (302) 778-7571
Fax: +1 (302) 658-5614

1201 Market Street, Suite 1500

Plaintiff

Warner-Lambert Export Ltd. Operating Company

Represented By

1 Attorneys Listed

Rudolf E. Hutz

Reed Smith LLP

Tel: +1 (302) 778-7571
Fax: +1 (302) 658-5614

1201 Market Street, Suite 1500

Warner-Lambert Company LLC Operating Company

Represented By

1 Attorneys Listed

Rudolf E. Hutz

Reed Smith LLP

Tel: +1 (302) 778-7571
Fax: +1 (302) 658-5614

1201 Market Street, Suite 1500

Pfizer Ireland Pharmaceuticals Operating Company

Represented By

1 Attorneys Listed

Rudolf E. Hutz

Reed Smith LLP

Tel: +1 (302) 778-7571
Fax: +1 (302) 658-5614

1201 Market Street, Suite 1500

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2008-12-17
1:08-cv-00948

Pfizer Inc. v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2008-12-17
1:08-cv-07231

Pfizer Inc. v. Apotex Inc.

Asserted Patent
Status: ILND
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5273995
[R-(R*R*)]-2-(4-fluorophenyl)-Ξ²,Ξ΄-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]- 1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
Filed: 1991-02-26
Issued: 1993-12-28
Expired (Term Ended)
Expires: 2011-02-26

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(6 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 03110000000000438970.) - filed by Pfizer Inc, Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company LLC, Warner-Lambert Export Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B Part 1, # 3 Exhibit B Part 2 of 2, # 4 Exhibit C, # 5 Civil Cover Sheet)(sns, ) (Entered: 04/28/2008)

Entry #1 • 2008-04-25
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (sns, ) Modified on 4/28/2008 (sns, ). (Entered: 04/28/2008)

Entry #2 • 2008-04-25
1

Disclosure Statement pursuant to Rule 7.1 filed by Pfizer Inc, Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company LLC, Warner-Lambert Export Ltd. identifying Corporate Parent Pfizer Inc for Pfizer Ireland Pharmaceuticals, Warner-Lambert Company LLC. (sns, ) (Entered: 04/28/2008)

Entry #3 • 2008-04-25
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,273,995; (sns, ) (Entered: 04/28/2008)

Entry #4 • 2008-04-25
1

Joint STIPULATION to consolidate case with CA No. 07-360-JJF by Pfizer Inc, Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company LLC, Warner-Lambert Export Ltd.. (Bove, Jeffrey) (Entered: 05/12/2008)

Entry #5 • 2008-05-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc